Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach. - Archive ouverte HAL Access content directly
Journal Articles Arthritis Research and Therapy Year : 2011

Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.

(1, 2) , (1) , (1, 3) , (4) , (1) , (1) , (5) , (1) , (1) , (2) , (1, 2)
1
2
3
4
5

Abstract

ABSTRACT: INTRODUCTION: Immunological studies of giant cell arteritis (GCA) suggest that a triggering antigen of unknown nature could generate a specific immune response. We thus decided to detect autoantibodies directed against endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in the serum of GCA patients and to identify their target antigens. METHODS: Sera from 15 GCA patients were tested in 5 pools of 3 patients' sera and compared to a sera pool from 12 healthy controls (HCs). Serum immunoglobulin G (IgG) reactivity was analysed by 2-D electrophoresis and immunoblotting with antigens from human umbilical vein ECs (HUVECs) and mammary artery VSMCs. Target antigens were identified by mass spectrometry. RESULTS: Serum IgG from GCA patients recognised 162 ± 3 (mean ± SD) and 100 ± 17 (mean ± SD) protein spots from HUVECs and VSMCs, respectively, and that from HCs recognised 79 and 94 protein spots, respectively. In total, 30 spots from HUVECs and 19 from VSMCs were recognised by at least two-thirds and three-fifths, respectively, of the pools of sera from GCA patients and not by sera from HCs. Among identified proteins, we found vinculin, lamin A/C, voltage-dependent anion-selective channel protein 2, annexin V and other proteins involved in cell energy metabolism and key cellular pathways. Ingenuity pathway analysis revealed that most identified target antigens interacted with growth factor receptor-bound protein 2. CONCLUSIONS: IgG antibodies to proteins in the proteome of ECs and VSMCs are present in the sera of GCA patients and recognise cellular targets that play key roles in cell biology and maintenance of homeostasis. Their potential pathogenic role remains to be determined.
Fichier principal
Vignette du fichier
ar3388.pdf (2 Mo) Télécharger le fichier
Vignette du fichier
AR3388-S1.DOC (56.5 Ko) Télécharger le fichier
Vignette du fichier
AR3388-S2.DOC (30 Ko) Télécharger le fichier
Vignette du fichier
AR3388-S3.PPT (167.5 Ko) Télécharger le fichier
Vignette du fichier
AR3388-S4.DOC (49 Ko) Télécharger le fichier
Vignette du fichier
AR3388-S5.PDF (539.9 Ko) Télécharger le fichier
Vignette du fichier
AR3388-S6.PPT (784 Ko) Télécharger le fichier
Vignette du fichier
AR3388-S7.DOC (52.5 Ko) Télécharger le fichier
Vignette du fichier
AR3388-S8.PPT (1023 Ko) Télécharger le fichier
Vignette du fichier
AR3388-S9.PPT (497 Ko) Télécharger le fichier
Vignette du fichier
ar3388.xml (121.57 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other

Dates and versions

inserm-00617297 , version 1 (26-08-2011)

Identifiers

Cite

Alexis Régent, Hanadi Dib, Kim Ly, Christian Agard, Mathieu Tamby, et al.. Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.. Arthritis Research and Therapy, 2011, 13 (3), pp.R107. ⟨10.1186/ar3388⟩. ⟨inserm-00617297⟩
119 View
334 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More